Source comparison
BPC-157 Studied Plantar Fasciitis: Clinical vs Research Context Comparison
Animal tendon injury models 30+ published studies showing accelerated healing, increased tensile strength, organised collagen deposition Research use only. Not subject to clinical regulation 10 mcg/kg daily subcutaneous or intraperitoneal injection for 14–28 d
This comparison does not assign a generated winner or score.
- Animal tendon injury models
- 30+ published studies showing accelerated healing, increased tensile strength, organised collagen deposition
- Research use only. Not subject to clinical regulation
- 10 mcg/kg daily subcutaneous or intraperitoneal injection for 14–28 days
- Measurable healing at 7–14 days, peak effect at 21–28 days
- Strong preclinical evidence. Mechanism is reproducible across injury types and consistent across research groups
- Human case reports (off-label use)
- Fewer than 20 documented cases in peer-reviewed literature. Mostly anecdotal reports from sports medicine practitioners
- Not FDA-approved, available through compounding pharmacies or research chemical suppliers
- 250–500 mcg daily subcutaneous injection (systemic or local) for 4–8 weeks
- Subjective pain reduction reported at 2–4 weeks in case reports, functional improvement at 4–6 weeks
- Insufficient data for evidence-based recommendation. Case reports lack controls, publication bias likely (negative outcomes underreported)
- Standard plantar fasciitis treatment (physical therapy, stretching, orthotics)
- Multiple randomised controlled trials, systematic reviews show 80–90% resolution at 6–12 months
- Standard of care, covered by insurance
- Daily stretching, eccentric loading exercises, heel cups or custom orthotics
- Gradual improvement over 3–6 months, 10–15% cases become chronic/refractory
- Gold standard first-line treatment. Evidence-based, low risk, no regulatory barriers
- Corticosteroid injection for plantar fasciitis
- Randomised trials show short-term pain relief (4–12 weeks) but no long-term benefit over placebo, risk of plantar fascia rupture
- FDA-approved corticosteroids used off-label for plantar fasciitis
- Single injection of 40 mg methylprednisolone or equivalent, repeat after 6 weeks if needed
- Pain reduction within 1–2 weeks, effect duration 4–12 weeks
- Effective for acute symptom relief but does not address underlying degenerative pathology. Fascia rupture risk (2–5% in studies) limits repeat use